X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (53) 53
Magazine Article (10) 10
Publication (3) 3
Conference Proceeding (2) 2
Patent (2) 2
Book Chapter (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13) 13
stroke (11) 11
aspirin (10) 10
humans (10) 10
clinical medicine (8) 8
klinisk medicin (8) 8
male (8) 8
medical and health sciences (8) 8
medicin och hälsovetenskap (8) 8
animals (7) 7
female (7) 7
middle aged (7) 7
abridged index medicus (6) 6
aged (6) 6
clinical neurology (6) 6
rats (6) 6
risk (6) 6
rivaroxaban (6) 6
anticoagulants (5) 5
cryptogenic stroke (5) 5
ischemia (5) 5
medical research (5) 5
peripheral vascular disease (5) 5
prevention (5) 5
acute coronary syndrome - drug therapy (4) 4
acute coronary syndromes (4) 4
cardiac & cardiovascular systems (4) 4
cardiac and cardiovascular systems (4) 4
clinical trials (4) 4
ischemic-stroke (4) 4
kardiologi (4) 4
medicine, experimental (4) 4
metaanalysis (4) 4
neurology (4) 4
patients (4) 4
reifenprofil (4) 4
thrombosis (4) 4
aspirin - therapeutic use (3) 3
atherosclerosis (3) 3
autoreifen (3) 3
bleeding (3) 3
cardiac arrhythmia (3) 3
cardiovascular diseases (3) 3
cardiovascular events (3) 3
coronary heart disease (3) 3
design (3) 3
dosage and administration (3) 3
double-blind method (3) 3
drug therapy (3) 3
electrocardiography (3) 3
factor xa inhibitors - therapeutic use (3) 3
heart attacks (3) 3
internal medicine (3) 3
medicine, general & internal (3) 3
myocardial infarction (3) 3
platelet aggregation inhibitors - therapeutic use (3) 3
rivaroxaban - therapeutic use (3) 3
treatment outcome (3) 3
acute myocardial-infarction (2) 2
adenosine - administration & dosage (2) 2
adenosine - analogs & derivatives (2) 2
aluminium alloys (2) 2
analysis (2) 2
angina (2) 2
angina pectoris (2) 2
aspirin - administration & dosage (2) 2
atrial fibrillation (2) 2
atrial-fibrillation (2) 2
behavioral sciences (2) 2
biomarkers (2) 2
blood pressure (2) 2
brain - physiology (2) 2
cardiac patients (2) 2
cardiology and cardiovascular medicine (2) 2
cardiovascular (2) 2
cardiovascular agents (2) 2
cardiovascular disease (2) 2
care and treatment (2) 2
cholesterol (2) 2
cholesterol, hdl - blood (2) 2
cholesterol, ldl - blood (2) 2
clinical-trials (2) 2
constraints (2) 2
diseases (2) 2
dose-response relationship, drug (2) 2
drinking (2) 2
drug dosages (2) 2
electric conductivity (2) 2
embolism (2) 2
embolisms (2) 2
engineering, mechanical (2) 2
feeding (2) 2
finite-elemente-methode (2) 2
flächenpressung (2) 2
geochemistry (2) 2
geochemistry & geophysics (2) 2
heart diseases (2) 2
heart-disease (2) 2
hemorrhage - chemically induced (2) 2
lauffläche (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Kasner, Scott E and Kasner, SE and Swaminathan, Balakumar and Lavados, Pablo and Lavados, P and Sharma, M and Sharma, Mukul and Muir, Keith and Muir, KW and Veltkamp, Roland and Veltkamp, R and Ameriso, Sebastian F and Ameriso, SF and Endres, M and Endres, Matthias and Lutsep, H and Lutsep, Helmi and Messé, Steven R and Spence, J David and Spence, D and Nedeltechev, Krassen and Perera, Kanjana and Perera, K and Santo, G and Santo, Gustavo and Olavarria, Veronica and Olavarria, V and Lindgren, Arne and Lindgren, A and Bangdiwala, Shrikant and Shoamanesh, Ashkan and Shoamanesh, A and Berkowitz, Scott D and Berkowitz, SD and Mundl, Hardi and Mundl, H and Connolly, Stuart J and Connolly, SJ and Hart, Robert G and Hart, RG and Abdelhamid, N and Abdul Rahman, D and Abdul-Saheb, M and Abreu, P and Abroskina, M and Abu Ahmad, F and Accassat, S and Acciaresi, M and Adami, A and Ahmad, N and Ahmed, F and Alberto Hawkes, M and Alemseged, F and Ali, A and Altavilla, R and Alwis, L and Amarenco, P and Amaro, S and Amaya Sanchez, LE and Amelia Pinto, A and Amin, H and Amino, T and Amjad, AK and Anagnostou, E and Andersen, G and Anderson, C and Anderson, DC and Andrea Falco, M and Andres Mackinnon, F and Andreu, D and Androulakis, M and Angel Gamero, M and Angel Saredo, G and Angeles Diaz, R and Angels Font, M and Anticoli, S and Arauz, A and Arauz Gongora, AA and Araya, P and Arenillas Lara, JF and Arias Rivas, S and Arnold, M and Augustin, S and Avelar, W and Azevedo, E and Babikian, V and Bacellar, A and Badalyan, K and Bae, HJ and Baez Martinez, EM and Bagelmann, H and Bailey, P and Bak, Z and Baker, M and Balazs, A and Baldaranov, D and Balogun, I and Balueva, T and Bankuti, Z and Bar, M and ... and NAVIGATE ESUS Investigators and Klinisk strokeforskning and EpiHealth: Epidemiology for Health and Clinical Stroke Research Group and Lund University and Lunds universitet
The Lancet Neurology, ISSN 1474-4422, 12/2018, Volume 17, Issue 12, pp. 1053 - 1060
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10081, pp. 1799 - 1808
Summary Background Dual antiplatelet therapy (DAPT), aspirin plus a P2Y12 inhibitor, is the standard antithrombotic treatment following acute coronary... 
Internal Medicine | Purinergic P2Y Receptor Antagonists - administration & dosage | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Myocardial Infarction - diagnostic imaging | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Coronary Angiography - methods | Adenosine - therapeutic use | Thrombolytic Therapy - methods | Ticlopidine - administration & dosage | Female | Myocardial Infarction - physiopathology | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Electrocardiography - methods | Purinergic P2Y Receptor Antagonists - therapeutic use | Rivaroxaban - therapeutic use | Double-Blind Method | Treatment Outcome | Adenosine - administration & dosage | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - drug therapy | Drug Therapy, Combination - methods | Factor Xa Inhibitors - therapeutic use | Myocardial Infarction - drug therapy | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Medical research | Medical colleges | Aspirin | Mortality | Cardiac patients | Clinical trials | Medicine, Experimental | Dosage and administration | Research institutes | France | Coronary heart disease | Analysis | Myocardial infarction | Therapy | Angiography | Medical services | Disorders | Angina | Bleeding | Elevation | Randomization | Motivation | Atherosclerosis | Safety | Drug therapy | Drug dosages | Heart diseases | Anticoagulants | Research & development--R&D | Strata | Coronary artery | Patients | Thrombosis | Thrombolysis | Inhibitors | Arteriosclerosis | Biomarkers | Infarction | Acute coronary syndromes | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 22, pp. 2089 - 2099
Dalcetrapib, an inhibitor of cholesteryl ester transfer protein, raises HDL cholesterol levels. In this clinical trial involving patients with an acute... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | STATIN THERAPY | CARDIOVASCULAR EVENTS | HIGH-RISK | HDL CHOLESTEROL | RANDOMIZED CONTROLLED-TRIAL | IT-TIMI 22 | TYPE-2 DIABETES-MELLITUS | HIGH-DENSITY-LIPOPROTEIN | ARTERY-DISEASE | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Risk | Secondary Prevention | Biomarkers - blood | Apolipoproteins - blood | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Sulfhydryl Compounds - adverse effects | Anticholesteremic Agents - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - mortality | Cholesterol, HDL - blood | Cholesterol, LDL - blood | Female | Aged | Blood Pressure - drug effects | Sulfhydryl Compounds - therapeutic use | C-Reactive Protein - analysis | Measurement | Cholesterol, HDL | Patient outcomes | Dosage and administration | Research | Acute coronary syndrome | Drug therapy | Health aspects | Cardiovascular agents | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | C-reactive protein | Heart attacks | Mortality | Cardiovascular disease | Angina | Coronary artery disease | Cholesterol | Cholesteryl ester transfer protein | Studies | Ischemia | Diet | Biomarkers | Blood pressure | Acute coronary syndromes | Cardiovascular diseases | Heart diseases | Lipoproteins (high density) | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 21, pp. 2267 - 2275
Journal Article